The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: Aromatase inhibitors in dietary supplements

    Aromatase inhibitors are a class of drugs used to treat breast cancer and ovarian cancer in postmenopausal women.

    Now, the FDA is recalling the following supplements that illegally contain these drugs.

    • Arom-X (see photo)
    • Arom-X UTT
    • Arom-XL, 4-AD
    • Decavol
    • ArimaDex
    • Clomed
    • Off Cycle II Hardcore
    • iForce – Reversitol

    Side effects associated with the use of aromatase inhibitors include the following.

    • Decreased rate of bone maturation and growth
    • Decreased sperm production
    • Infertility
    • Aggressive behavior
    • Adrenal insufficiency
    • Kidney failure
    • Liver dysfunction

    Consumers with liver, kidney, adrenal, or prostate abnormalities are at higher risk for developing side effects.

    The bottom line?

    If you have any of these products in your possession stop using it immediately.

    If you experience any side effects due to its consumption contact a physician.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

    9/20/10 12:33 JR

    Leave a Comment

    You must be logged in to post a comment.